Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Cash flow

2 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Cash Flow

HK:9989's free cash flow for Q4 2025 was ¥245.47M. For the 2025 fiscal year, HK:9989's free cash flow was decreased by ¥-399.51M and operating cash flow was ¥272.00M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Mar 22
Operating Cash Flow	¥ 1.71B	¥ 2.19B	¥ 398.22M	¥ -756.61M	¥ -6.63M
Investing Cash Flow	¥ -872.75M	¥ -415.05M	¥ 1.22B	¥ 249.84M	¥ 719.93M
Financing Cash Flow	¥ -1.09B	¥ -2.14B	¥ -1.21B	¥ 329.56M	¥ -501.08M
End Cash Position	¥ 1.19B	¥ 1.42B	¥ 1.77B	¥ 1.32B	¥ 1.48B
Free Cash Flow	¥ 1.59B	¥ 1.99B	¥ -46.66M	¥ -979.03M	¥ -200.49M

Currency in CNY